Table 1.
Patient and Tumor Characteristics for Patients
| Variable | All Patients (n=17) Value or No. (%) |
|---|---|
| Follow-up time from dx, months | |
| Median | 89 |
| IQR | 62–160 |
| Follow-up time from start of IO, months | |
| Median | 29 |
| IQR | 13–35 |
| Age at initial dx, years | |
| Median | 56 |
| IQR | 52–65 |
| Sex | |
| Female | 4 (24) |
| Male | 13 (76) |
| Race | |
| Black | 1 (6) |
| Asian | 1 (6) |
| Hispanic | 2 (12) |
| Non-Hispanic white | 13 (76) |
| Primary Tumor Location | |
| Sacrum | 10 (59) |
| Mobile Spine | 5 (29) |
| Base of Skull | 2 (12) |
| PD-L1 Staining | |
| Positive | 4 (24) |
| Negative | 5 (29) |
| Not tested | 8 (47) |
| Disease Status Prior to IO | |
| Localized | 5 (29) |
| Regional | 5 (29) |
| Metastatic | 7 (42) |
| Disease Status at LFU | |
| Alive with Disease | 12 (71) |
| Dead with Disease | 4 (24) |
| No evidence of Disease | 1 (6) |
Abbreviations: IQR, interquartile range; IO, immunotherapy; dx, diagnosis